Market Overview:
The global oxytocin market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for oxytocin in various applications such as for baby born, for cosmetic, and others. Moreover, the increasing awareness about the benefits of oxytocin is also contributing to the growth of this market. However, stringent regulatory norms related to manufacturing and distribution of oxytocin are restraining the growth of this market. On basis on type, dry powder oxygen accounts for major share in global Oxytocin Market and is projected grow at highest CAGR during forecast period due its advantages over other forms such as easy handling and storage with longer shelf life etc., followed by Oxytocin Injection segment . In terms regional analysis North America holds largest share in Global Oxycotcin Market while Asia Pacific region is projected show highest CAGR during forecast period .
Product Definition:
Oxytocin is a hormone that is released by the pituitary gland. It plays an important role in childbirth and breast-feeding. Oxytocin causes the muscles of the uterus to contract, which helps push the baby out during labor. Oxytocin also causes milk to flow from the breasts during breast-feeding.
Oxytocin Injection:
Oxytocin is a hormone that is produced in the human body and it plays an important role in childbirth. It is also used as a medication for women to help them deliver babies. Oxytocin injection helps initiate contractions during labor, after which it can be administered through an IV or inserted into the muscle (intravenous). The drug has several benefits such as reduced blood loss during delivery, low risk of infection transmission and improved patient satisfaction & breastfeeding rate.
Dry Powder Oxytocin:
Dry powder oxytocin (OxyContin) is a form of oxytocin used to treat labor and birth defects. It is available as an oral drug in the form of tablets or a solution for injection. OxyContin has been approved by the Food and Drug Administration (FDA) for treating labor pain in women throughout pregnancy, provided that they are breast-feeding.
Application Insights:
The market is categorized into four segments based on application, which includes for baby born, for domestic, others and unani/TCP. The other segment held the largest share of the global market in 2017. This can be attributed to growing awareness about bonding and new-born care among women. In addition, growing emphasis on family planning by governments across the world has led to an increase in number of childbirths which has further increased demand for oxytocin products globally.
For baby born application segment is expected to grow at a fastest CAGR during forecast period owing to increasing number of childbirths due largely female reproductive health issues such as postmenopausal osteoporosis that require medical attention before pregnancy or within first trimester leading up till delivery date Oxytocin injection helps strengthen contractions.
Regional Analysis:
North America dominated the global market in 2017 owing to rising awareness about the product and increasing demand for technologically advanced products. The region is expected to witness a CAGR of XX% during the forecast period. Increasing number of cesarean section deliveries has led to an increase in demand for oxytocin, which is further fueling growth.
Asia Pacific is anticipated to be one of the fastest-growing regions during the same period owing to growing population and improving healthcare infrastructure leading to an increase in birth rate, thus driving growth.
Growth Factors:
- Increasing demand for oxytocin in the medical and pharmaceutical industries for various applications such as labor induction, postpartum hemorrhage, and autism.
- Rising awareness about the benefits of oxytocin therapy among pregnant women and healthcare professionals.
- Growing number of research studies on the therapeutic potential of oxytocin for various diseases and disorders.
- increasing investments by pharmaceutical companies in R&D activities to develop novel formulations of oxytocin drugs.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oxytocin Market Research Report
By Type
Oxytocin Injection, Dry Powder Oxytocin
By Application
For Baby Born, For Comestic, Others
By Companies
Merck & Co, Pfizer, Mylan, GSK, Novartis, Roche, Grindeks
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Oxytocin Market Report Segments:
The global Oxytocin market is segmented on the basis of:
Types
Oxytocin Injection, Dry Powder Oxytocin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
For Baby Born, For Comestic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck & Co
- Pfizer
- Mylan
- GSK
- Novartis
- Roche
- Grindeks
Highlights of The Oxytocin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oxytocin Injection
- Dry Powder Oxytocin
- By Application:
- For Baby Born
- For Comestic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oxytocin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oxytocin is a hormone that is produced in the hypothalamus and released into the bloodstream. Oxytocin plays an important role in social behavior, childbirth, lactation, and sexual activity.
Some of the major players in the oxytocin market are Merck & Co, Pfizer, Mylan, GSK, Novartis, Roche, Grindeks.
The oxytocin market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oxytocin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oxytocin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oxytocin Market - Supply Chain
4.5. Global Oxytocin Market Forecast
4.5.1. Oxytocin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oxytocin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oxytocin Market Absolute $ Opportunity
5. Global Oxytocin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oxytocin Market Size and Volume Forecast by Type
5.3.1. Oxytocin Injection
5.3.2. Dry Powder Oxytocin
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oxytocin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oxytocin Market Size and Volume Forecast by Application
6.3.1. For Baby Born
6.3.2. For Comestic
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oxytocin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oxytocin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oxytocin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oxytocin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oxytocin Demand Share Forecast, 2019-2026
9. North America Oxytocin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oxytocin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oxytocin Market Size and Volume Forecast by Application
9.4.1. For Baby Born
9.4.2. For Comestic
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oxytocin Market Size and Volume Forecast by Type
9.7.1. Oxytocin Injection
9.7.2. Dry Powder Oxytocin
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oxytocin Demand Share Forecast, 2019-2026
10. Latin America Oxytocin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oxytocin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oxytocin Market Size and Volume Forecast by Application
10.4.1. For Baby Born
10.4.2. For Comestic
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oxytocin Market Size and Volume Forecast by Type
10.7.1. Oxytocin Injection
10.7.2. Dry Powder Oxytocin
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oxytocin Demand Share Forecast, 2019-2026
11. Europe Oxytocin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oxytocin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oxytocin Market Size and Volume Forecast by Application
11.4.1. For Baby Born
11.4.2. For Comestic
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oxytocin Market Size and Volume Forecast by Type
11.7.1. Oxytocin Injection
11.7.2. Dry Powder Oxytocin
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Cuntry
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oxytocin Demand Share, 2019-2026
12. Asia Pacific Oxytocin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oxytocin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oxytocin Market Size and Volume Forecast by Application
12.4.1. For Baby Born
12.4.2. For Comestic
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oxytocin Market Size and Volume Forecast by Type
12.7.1. Oxytocin Injection
12.7.2. Dry Powder Oxytocin
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oxytocin Demand Share, 2019-2026
13. Middle East & Africa Oxytocin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oxytocin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oxytocin Market Size and Volume Forecast by Application
13.4.1. For Baby Born
13.4.2. For Comestic
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oxytocin Market Size and Volume Forecast by Type
13.7.1. Oxytocin Injection
13.7.2. Dry Powder Oxytocin
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oxytocin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oxytocin Market: Market Share Analysis
14.2. Oxytocin Distributors and Customers
14.3. Oxytocin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Merck & Co
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Pfizer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Mylan
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. GSK
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Novartis
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Roche
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Grindeks
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
